87 results
Page 4 of 5
6-K
EX-10.1
vezr b0k1ni9sp
23 Sep 19
Anchiano Therapeutics Enters into An Exclusive Option To License Agreement for Novel Pan-RAS Inhibitor and PDE10/β-catenin Inhibitor Programs
5:29pm
20-F/A
xiso8z
24 Apr 19
Annual report (foreign) (amended)
5:19pm
6-K
EX-1.1
1hrun
14 Feb 19
Current report (foreign)
4:40pm
6-K
EX-4.1
9uzbu5krbjj
14 Feb 19
Current report (foreign)
4:40pm
424B4
mry swei50
13 Feb 19
Prospectus supplement with pricing info
8:20am
F-1/A
euaeukb2j0u
11 Feb 19
Registration statement (foreign) (amended)
9:52am
F-1/A
EX-4.1
htym uflu2nq
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
0y0itkasa2q3
8 Feb 19
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-4.1
tx79sb7vmmviu 8oqep
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
EX-10.3
qznv9sgmnov4o
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
EX-1.1
6kes b6bm
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
cx543oaz
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1/A
EX-1.1
azoag3t29v 1n
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-10.5
yelq07zla ijsok
7 Jan 19
Registration statement (foreign)
5:11pm
F-1
ix5k3o7mugj
7 Jan 19
Registration statement (foreign)
5:11pm
DRS/A
1jhu2ur
27 Nov 18
Draft registration statement (amended)
12:00am
DRS/A
EX-10.5
xtc narle3hi6pt
27 Nov 18
Draft registration statement (amended)
12:00am
DRS
5j72bn7nrs d1jq
28 Sep 18
Draft registration statement
12:00am
20-F
EX-4.15
ufx317m 9saym6gwhhoz
23 Apr 13
Annual report (foreign)
12:00am